Drug Delivery. Proprietary foam products, for topical delivery of
skin diseases, gynecological disorders and cosmetic applications.
Employees: 31
Overview
FOAMIX LTD. is a leader in the development of delivery platforms
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
for proprietary topical foam products for Dermatology,
Gynecology, Cosmetics, Wound and Burn Healing.
FOAMIX foams differ from existing products in that they are
emollient-based and do not contain any alcohol. Thus, they
provide improved treatment convenience, better skin
moisturization and protection with no irritability.
FOAMIX foam products are suitable for use in the fields of
Dermatology, Gynecology, Cosmetics, Wound and Burn Healing.
FOAMIX foams are different from existing products in that they
are emollient-based and do not contain any alcohol. Thus, they
provide improved treatment convenience, better skin
moisturization and protection with no irritability.
Currently, FOAMIX is engaged in the development of a number of
delivery platforms, which address a number of fields. These
include:
* DermaFoamix - a suitable vehicle for a variety of drugs,
including antibacterials, anti-fungal drugs, corticosteroids,
anti-psoriasis agents, immunomodulators and wound and burn-care
agents.
* GyneFoamix - proprietary foam formulations for gynecological
drugs.
* Suspension Foam - unique foams comprising insoluble drugs and
cosmetic agents.
* BabyFoamix - foam formulations for the prevention and treatment
of diaper rash and delicate baby skin care foams.
* CosmetoFoamix - creative cosmetic foam formulations, for
elegant and effective dermo-cosmetic treatment of large skin
surfaces.
* OILGEL - semi-solid until applied to the skin, where it
transforms to a rapidly absorbed liquid.
FOAMIX offers access to its foam technology platforms to
companies developing new dermatological and gynecological drugs,
as well as companies looking for a product-life-cycle extension
and a new topical drug delivery system of choice.
Typically, FOAMIX signs license agreements with pharmaceutical
partners, on a drug by drug basis. The company has hitherto been
successful in signing co-development and license agreements with
leading pharmaceutical companies and meeting pivotal development
milestones. FOAMIX is actively seeking further co-development and
marketing partners for its product pipeline.
In parallel, FOAMIX develops in-house proprietary topical foam
drug products, Over-the-Counter (OTC) products and Cosmetics,
which will be sold through various marketing and sales channels.
